Home » Stocks » CNMD

CONMED Corporation (CNMD)

Stock Price: $143.65 USD 1.13 (0.79%)
Updated May 7, 2021 4:00 PM EDT - Market closed
Market Cap 4.15B
Revenue (ttm) 881.13M
Net Income (ttm) 13.45M
Shares Out 28.97M
EPS (ttm) 0.44
PE Ratio 325.00
Forward PE n/a
Dividend $0.80
Dividend Yield 0.56%
Trading Day May 7
Last Price $143.65
Previous Close $142.52
Change ($) 1.13
Change (%) 0.79%
Day's Open 142.49
Day's Range 141.69 - 144.21
Day's Volume 237,506
52-Week Range 60.13 - 146.95

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

CONMED (CNMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

1 week ago - Zacks Investment Research

CONMED (CNMD) witnesses growth in revenues in both its segments during Q1.

1 week ago - Zacks Investment Research

Conmed (CNMD) delivered earnings and revenue surprises of 46.51% and 7.01%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Shares of Conmed (NYSE:CNMD) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 23.53% over the past year to $0.63, which beat the estimat...

1 week ago - Benzinga

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2021. First Quarter 2021 Highlights Sales of $232.7 million increase...

1 week ago - Business Wire

Conmed (NYSE:CNMD) announces its next round of earnings this Wednesday, April 28. Here is Benzinga's everything-that-matters guide for this Wednesday's Q1 earnings announcement.

1 week ago - Benzinga

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 weeks ago - Zacks Investment Research

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2021 after the market close on Wednesday, April 28, 2021. The Co...

1 month ago - Business Wire

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Annual Meeting of Stockholders will be held as a virtual meeting on Wednesday, May 19, 2021, at 1:30 p.m. ET. Share...

1 month ago - Business Wire

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice Preside...

1 month ago - Business Wire

Investor optimism is high on CONMED (CNMD) stock, courtesy of its solid prospects.

2 months ago - Zacks Investment Research

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2021 to all share...

2 months ago - Business Wire

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice Preside...

2 months ago - Business Wire

Despite weak segmental performance in fourth quarter, CONMED (CNMD) showed strength and resilience in amid a tough operating environment.

3 months ago - Zacks Investment Research

CONMED Corporation (CNMD) CEO Curt Hartman on Q4 2020 Results - Earnings Call Transcript

3 months ago - Seeking Alpha

Conmed (CNMD) delivered earnings and revenue surprises of 7.69% and -3.91%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of Conmed (NYSE:CNMD) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 6.67% over the past year to $0.84, which beat the est...

3 months ago - Benzinga

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter ended December 31, 2020. Fourth Quarter 2020 Highlights Sales of $252.8 million dec...

3 months ago - Business Wire

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter and full year 2020 after the market close on Wednesday, January...

3 months ago - Business Wire

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President & Chief Executive Officer, and Todd W. Garner, Executive Vice President ...

4 months ago - Business Wire

MCK vs. CNMD: Which Stock Is the Better Value Option?

Other stocks mentioned: MCK
4 months ago - Zacks Investment Research

Investor confidence is high on CONMED (CNMD) stock, thanks to solid prospects.

5 months ago - Zacks Investment Research

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President, Chief Executive Officer and Chair of the Board, and Todd W. Garner, Executive Vice Presiden...

5 months ago - Business Wire

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2021 to all sha...

5 months ago - Business Wire

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its presentation time at the Jefferies Virtual London Healthcare Conference has been changed to 11:25 a.m. ET on Wednes...

5 months ago - Business Wire

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Jefferies Virtual London Heal...

5 months ago - Business Wire

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President, Chief Executive Officer and Chair of the Board, and Todd W. Garner, Executive Vice Presiden...

6 months ago - Business Wire

CONMED's (CNMD) General Surgery unit witnessed revenue growth in Q3

6 months ago - Zacks Investment Research

CONMED Corporation's (CNMD) CEO Curt Hartman on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Conmed (CNMD) delivered earnings and revenue surprises of 252.00% and 16.07%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Shares of Conmed (NYSE:CNMD) decreased 2.4% in after-market trading after the company reported Q3 results. Quarterly Results

6 months ago - Benzinga

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Highlights Sales of $237.8 million incr...

6 months ago - Business Wire

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter of 2020 after the market close on Wednesday, October 28, 2020. T...

7 months ago - Business Wire

Investor confidence is high on CONMED (CNMD) stock, thanks to solid prospects.

8 months ago - Zacks Investment Research

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R.

8 months ago - Business Wire

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Other stocks mentioned: PDCO
8 months ago - Zacks Investment Research

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2020 to all sha...

8 months ago - Business Wire

CONMED's (CNMD) core units - General Surgery and Orthopedic Surgery - witnessed revenue decline in Q2.

9 months ago - Zacks Investment Research

CONMED Corporation's (CNMD) CEO Curt Hartman on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Conmed (CNMD) delivered earnings and revenue surprises of 93.14% and 22.20%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Shares of Conmed (NYSE:CNMD) moved higher by 4.42% in after-market trading after the company reported Q2 results.

9 months ago - Benzinga

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2020.

9 months ago - Business Wire

On Wednesday, July 29, Conmed (NYSE: CNMD) will report its last quarter's earnings.

9 months ago - Benzinga

CONMED (CNMD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

9 months ago - Zacks Investment Research

Conmed (CNMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

9 months ago - Zacks Investment Research

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Other stocks mentioned: PDCO
9 months ago - Zacks Investment Research

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?

11 months ago - Zacks Investment Research

CONMED (CNMD) continues to benefit from broad product portfolio and persistent focus on R&D. However, forex remains a woe.

11 months ago - Zacks Investment Research

About CNMD

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric,... [Read more...]

Industry
Medical Devices
IPO Date
Jul 23, 1987
CEO
Curt Hartman
Employees
3,400
Stock Exchange
NYSE
Ticker Symbol
CNMD
Full Company Profile

Financial Performance

In 2020, CNMD's revenue was $862.46 million, a decrease of -9.70% compared to the previous year's $955.10 million. Earnings were $9.52 million, a decrease of -66.75%.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for CNMD stock is "Buy." The 12-month stock price forecast is 152.00, which is an increase of 5.81% from the latest price.

Price Target
$152.00
(5.81% upside)
Analyst Consensus: Buy